Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Completion of Share Buyback Programme

22 Dec 2025 11:50

RNS Number : 4926M
Coca-Cola Europacific Partners plc
22 December 2025
 

Coca-Cola Europacific Partners plc (the "Company")Completion of Share Buyback Programme

 

The Company today announces that it has completed the share buyback programme (the "Programme") announced on 14 February 2025 to purchase up to a maximum aggregate amount of EUR 1 billion of the Company's ordinary shares.

The Company announces that 12,718,173 ordinary shares were repurchased under the Programme, for aggregate consideration of approximately EUR 999,998,769.23.[1]

As a result, the Company has returned EUR 999,998,769.23 to its shareholders through the completion of the Programme.

 

CONTACTS

Company Secretariat

Clare Wardle

clare.wardle@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ (and a constituent of the NASDAQ 100), London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP (ISIN No. GB00BDCPN049).

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

 

 

 

 


[1] The aggregate consideration of approximately EUR 999,998,769.23 is comprised of USD 832,273,272 spent on acquiring shares on the US Trading Venues (which comprise Nasdaq and other applicable US trading venues) and GBP 234,969,006 spent on acquiring depository interests on the London Trading Venues (which comprise the London Stock Exchange, CBOE Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis) over the course of the Programme.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFEWFFEEISEFE
Date   Source Headline
1st Sep 20203:00 pmRNSTotal Voting Rights
21st Aug 20204:30 pmRNSDirector/PDMR Shareholding
11th Aug 202012:00 pmRNSDirector/PDMR Shareholding
6th Aug 20207:00 amRNSH1 2020 Results & COVID-19 Update
3rd Aug 20206:00 pmRNSDirectorate Change
3rd Aug 20202:00 pmRNSTotal Voting Rights
27th Jul 20204:35 pmRNSPrice Monitoring Extension
23rd Jul 20201:30 pmRNSDirector/PDMR Shareholding
14th Jul 20205:30 pmRNSDirectorate Change
1st Jul 20201:00 pmRNSTotal Voting Rights
23rd Jun 20205:30 pmRNSDirector/PDMR Shareholding
9th Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
1st Jun 20201:30 pmRNSTotal Voting Rights
28th May 20201:30 pmRNSResult of AGM
20th May 20204:00 pmRNSDirector/PDMR Shareholding
15th May 202010:30 amRNSLetter to Shareholders
1st May 20204:30 pmRNSAnnual report on remuneration 2019 - correction
1st May 20201:00 pmRNSTotal Voting Rights
28th Apr 20209:06 amRNSPost Stab Notice: Coca-Cola European Partners plc
28th Apr 20207:00 amRNSQ1 2020 & COVID-19 Update
22nd Apr 20204:45 pmRNSDirector/PDMR Shareholding
17th Apr 20205:00 pmRNSBlock listing Interim Review
16th Apr 202011:00 amRNSNotice of AGM
1st Apr 20204:30 pmRNSTotal Voting Rights
30th Mar 20204:45 pmRNSDirector/PDMR Shareholding
30th Mar 202012:00 pmRNSHolding(s) in Company
25th Mar 20204:30 pmRNSDirector/PDMR Shareholding
24th Mar 20209:11 amRNSStabilisation Notice: Coca-Cola European Partners
23rd Mar 20204:25 pmRNSTransaction in Own Shares
23rd Mar 20207:00 amRNSFY20 GUIDANCE WITHDRAWAL, SHARE BUYBACK SUSPENSION
20th Mar 20205:00 pmRNSDirector/PDMR Shareholding
18th Mar 20205:30 pmRNSDirector/PDMR Shareholding
18th Mar 20204:44 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20202:30 pmRNSDirector/PDMR Shareholding
16th Mar 20206:00 pmRNSTransaction in Own Shares
16th Mar 20207:04 amRNSAnnual Financial Report
11th Mar 20203:30 pmRNSDirectorate Change
9th Mar 20203:15 pmRNSTransaction in Own Shares
6th Mar 202012:21 pmRNSRelease of the Guarantee
2nd Mar 20205:00 pmRNSTotal Voting Rights
2nd Mar 20204:00 pmRNSTransaction in Own Shares
24th Feb 20201:00 pmRNSTransaction in Own Shares
21st Feb 20204:00 pmRNSDirector/PDMR Shareholding
13th Feb 20207:00 amRNSPreliminary Unaudited Results FY 31 Dec 2019
3rd Feb 20202:00 pmRNSTotal Voting Rights
22nd Jan 20204:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.